Reid's CF Regenerative Medicine Column

reid patient's

At the time of writing this column, Reid had started his PhD in biomedical engineering at Vanderbilt University. He used an engineering approach to research pulmonary hypertension. Reid has CF, and finds much of his drive by experiencing both the research and patient aspects of cystic fibrosis. Reid has also served as a director at the U.S. Adult Cystic Fibrosis Association.

Endogenous Lung Stem Cells and Cystic Fibrosis, an Introduction

My past few articles have touched upon the application of stem cells for the treatment of cystic fibrosis (CF), and while some of these treatments demonstrate great promise for the future of CF, it is important to establish more necessary discourse. With my past articles discussing Embryonic Stem Cells (ESCs),…

Regenerative Medicine Study Underscores Lung Regeneration Capacity

In diseases like cystic fibrosis, the lungs undergo constant healing and remodeling due to chronic infections. To better understand the repair mechanisms the lungs go through in diseases like CF and COPD, scientists have paid great attention to studying cellular regeneration. Scientists at the University of Pennsylvania and Duke University have discovered…

Biomedical Engineering Student With CF Offers Perspective On How Regenerative Medicine Could Someday Treat the Disease

Reid D’Amico is a biomedical engineering PhD student with Cystic Fibrosis. He is currently pursuing PhD research to combine both engineering and pulmonary research, an emerging branch of regenerative medicine that he believes could play a major role in next-generation CF therapy. Reid plans on contributing to Cystic Fibrosis News Today in a…